Anergy in cancer

Evan M Hersh, J. U. Gutterman, G. M. Mavligit

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Immunologic deficiency as manifested by cutaneous anergy is an important component of the malignant process. The presence of anergy, either to nontumor specific or tumor specific antigens, carries a grim prognosis for the cancer patient. The etiology of this immunodeficiency is complex and only partially understood. It involves a multiplicity of intrinsic and environmental factors as well as factors directly related to the tumor. However, this immunodeficiency is subjected to modification and correction by various therapeutic maneuvers. The study and further characterization of the immunodeficiency associated with cancer are quite important in regard to understanding the pathogenesis of the disease and in regard to developing new and improved approaches to therapy.

Original languageEnglish (US)
Pages (from-to)112-120
Number of pages9
JournalInternational Journal of Dermatology
Volume15
Issue number2
StatePublished - 1976
Externally publishedYes

Fingerprint

Neoplasms
Intrinsic Factor
Neoplasm Antigens
Skin
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Hersh, E. M., Gutterman, J. U., & Mavligit, G. M. (1976). Anergy in cancer. International Journal of Dermatology, 15(2), 112-120.

Anergy in cancer. / Hersh, Evan M; Gutterman, J. U.; Mavligit, G. M.

In: International Journal of Dermatology, Vol. 15, No. 2, 1976, p. 112-120.

Research output: Contribution to journalArticle

Hersh, EM, Gutterman, JU & Mavligit, GM 1976, 'Anergy in cancer', International Journal of Dermatology, vol. 15, no. 2, pp. 112-120.
Hersh EM, Gutterman JU, Mavligit GM. Anergy in cancer. International Journal of Dermatology. 1976;15(2):112-120.
Hersh, Evan M ; Gutterman, J. U. ; Mavligit, G. M. / Anergy in cancer. In: International Journal of Dermatology. 1976 ; Vol. 15, No. 2. pp. 112-120.
@article{da8b49f09a904177820d53f780988075,
title = "Anergy in cancer",
abstract = "Immunologic deficiency as manifested by cutaneous anergy is an important component of the malignant process. The presence of anergy, either to nontumor specific or tumor specific antigens, carries a grim prognosis for the cancer patient. The etiology of this immunodeficiency is complex and only partially understood. It involves a multiplicity of intrinsic and environmental factors as well as factors directly related to the tumor. However, this immunodeficiency is subjected to modification and correction by various therapeutic maneuvers. The study and further characterization of the immunodeficiency associated with cancer are quite important in regard to understanding the pathogenesis of the disease and in regard to developing new and improved approaches to therapy.",
author = "Hersh, {Evan M} and Gutterman, {J. U.} and Mavligit, {G. M.}",
year = "1976",
language = "English (US)",
volume = "15",
pages = "112--120",
journal = "International Journal of Dermatology",
issn = "0011-9059",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Anergy in cancer

AU - Hersh, Evan M

AU - Gutterman, J. U.

AU - Mavligit, G. M.

PY - 1976

Y1 - 1976

N2 - Immunologic deficiency as manifested by cutaneous anergy is an important component of the malignant process. The presence of anergy, either to nontumor specific or tumor specific antigens, carries a grim prognosis for the cancer patient. The etiology of this immunodeficiency is complex and only partially understood. It involves a multiplicity of intrinsic and environmental factors as well as factors directly related to the tumor. However, this immunodeficiency is subjected to modification and correction by various therapeutic maneuvers. The study and further characterization of the immunodeficiency associated with cancer are quite important in regard to understanding the pathogenesis of the disease and in regard to developing new and improved approaches to therapy.

AB - Immunologic deficiency as manifested by cutaneous anergy is an important component of the malignant process. The presence of anergy, either to nontumor specific or tumor specific antigens, carries a grim prognosis for the cancer patient. The etiology of this immunodeficiency is complex and only partially understood. It involves a multiplicity of intrinsic and environmental factors as well as factors directly related to the tumor. However, this immunodeficiency is subjected to modification and correction by various therapeutic maneuvers. The study and further characterization of the immunodeficiency associated with cancer are quite important in regard to understanding the pathogenesis of the disease and in regard to developing new and improved approaches to therapy.

UR - http://www.scopus.com/inward/record.url?scp=0017262462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017262462&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 112

EP - 120

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 2

ER -